Level Four Advisory Services LLC decreased its position in Balchem Co. (NASDAQ:BCPC – Free Report) by 8.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,104 shares of the basic materials company’s stock after selling 531 shares during the quarter. Level Four Advisory Services LLC’s holdings in Balchem were worth $995,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the company. Westside Investment Management Inc. acquired a new position in Balchem in the third quarter worth $27,000. R Squared Ltd bought a new position in shares of Balchem in the 4th quarter worth about $29,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Balchem in the 3rd quarter valued at about $35,000. Venturi Wealth Management LLC bought a new stake in shares of Balchem during the 4th quarter valued at about $95,000. Finally, Smartleaf Asset Management LLC raised its stake in Balchem by 230.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock worth $106,000 after acquiring an additional 450 shares during the period. 87.91% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have commented on BCPC shares. Sidoti upgraded Balchem to a “hold” rating in a research note on Tuesday, February 25th. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $190.00 target price on shares of Balchem in a research report on Monday, February 24th.
Balchem Price Performance
NASDAQ BCPC opened at $163.79 on Monday. The company has a 50-day moving average price of $165.26 and a two-hundred day moving average price of $169.28. The stock has a market cap of $5.33 billion, a price-to-earnings ratio of 41.68, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03.
Balchem (NASDAQ:BCPC – Get Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Analysts forecast that Balchem Co. will post 4.64 EPS for the current year.
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- How to Profit From Value Investing
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Market Cap Calculator: How to Calculate Market Cap
- MarketBeat Week in Review – 03/24 – 03/28
- Investing in Travel Stocks Benefits
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.